Sun Pharma Advanced Research Company Limited has informed the Exchange about Copy of Newspaper Publication
SPARC · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sun Pharma Advanced Research Company (SPARC) has submitted copies of newspaper advertisements published on May 21, 2025 in Financial Express (English, all editions) and Financial Express (Gujarati, Ahmedabad edition). The ads contained the extract of the company's audited financial results, both standalone and consolidated, for the quarter and financial year ended March 31, 2025. This filing is made under Regulation 30 and 47 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, as a standard compliance requirement. The full results are also hosted on the company's website at sparc.life. Signed by Kajal Damania, Company Secretary and Compliance Officer.
This is a routine regulatory compliance filing and does not contain any new financial information beyond what was already disclosed in SPARC's Q4 and FY25 audited results. No direct impact on shareholders or stock price is expected from this disclosure itself.